A new centre has been established by the FDA that will allow the agency to improve the quality and safety of compounded drugs by providing educational programmes to outsourcing facilities.
List view / Grid view
Filter the results
Partnering for product characterisation can streamline drug development and create efficiencies in moving from concept to clinic.
The dose CMO industry is performing strongly despite challenges of increasingly complex drug production, says a new report.
At Lonza Pharma & Biotech we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need.
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.
The FDA says that even though it recognises the importance of compounded drugs, they also pose a risk to patient safety.
Under the microscope: A global perspective – Eurofins Professional Scientific Services Insourcing Solutions
In this interview, Beth DiPaolo, President and Global Head of Eurofins Professional Scientific Services (PSS) Insourcing Solutions, provides intelligence on their global service offerings.
Regulatory expectations nowadays focus on harmonisation of global regulations. This whitepaper by PQE looks at current and emerging trends in regulatory expectations.
The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution...